언어 선택

DRD1

DRD1 분자 정보

영어 이름	Dopamine D1 receptor	시판 약물 수	10
임상 약물 수	15	표적 별명	D(1A) dopamine receptor，DRD1，Dopamine Receptor D1，Dopamine D1 Receptor，DRD1A，DADR，Receptors， Dopamine D1
최고 연구 개발 단계	Approved

영어 이름	Dopamine D1 receptor
표적 별명	D(1A) dopamine receptor，DRD1，Dopamine Receptor D1，Dopamine D1 Receptor，DRD1A，DADR，Receptors， Dopamine D1
시판 약물 수	10
임상 약물 수	15
최고 연구 개발 단계	Approved

DRD1 제품 목록

속성
Protein (1)
제품 라이브러리
온라인 (1)
종
Human (1)
태그
- (1)
마커
Unconjugated (1)

제품 번호	종	발현 시스템	제품 설명	단백질 구조	순도	특성
DR1-H52P6	Human	HEK293	Human DRD1 Full Length Protein (VLP)

총 수량1

DRD1분자 배경

The dopamine receptor D1 (Drd1) is a member of the D1-like receptor family and is the most abundant dopamine receptor in the central nervous system. The receptor is found in the cortex, striatum and limbic system of the brain and the cardiovascular system.

DRD1분자 별명

DRD1,Dopamine D1 receptor,D1R; DADR; DRD1A

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
Ecopipam	PSYRX-101; Sch-39166	Phase 3 Clinical	Merck Sharp & Dohme Corp	Childhood-Onset Fluency Disorder; Gambling; Language Disorders; Lesch-Nyhan Syndrome; Self-Injurious Behavior; Speech Disorders; Stuttering; Tourette Syndrome	상세
Olanzapine transdermal patch (Starton Therapeutics)	CMIO-OLANZ; CHEMIO OLANZ; CMIO-OLNZ; STAR-OLZ	Phase 3 Clinical	Starton Therapeutics Inc	Nausea; Vomiting	상세
Olanzapine/samidorphan (Qilu Pharmaceutical)		Phase 3 Clinical	Qilu Pharmaceutical Co Ltd	Schizophrenia	상세
PF-06412562	PF-6412562; PF-06412562; PF-2562; CVL-562	Phase 2 Clinical	Pfizer Inc	Parkinson Disease; Schizophrenia; Schizophrenia Spectrum and Other Psychotic Disorders	상세
Mevidalen	LY-3154207	Phase 2 Clinical	Eli Lilly And Company	Alzheimer Disease; Lewy Body Disease; Parkinson Disease	상세
TGOF02N	TGOF-02N; TGOF02N; FKF02SC	Phase 2 Clinical	Fabre-Kramer	Schizophrenia	상세
Docarpamine (Martin Pharmaceuticals)		Phase 2 Clinical	Martin Pharmaceuticals Inc	Gastrointestinal Diseases; Liver Cirrhosis; Mouth Diseases	상세
Glovadalen	UCB-0022	Phase 2 Clinical	Ucb Biopharma Srl	Parkinson Disease	상세
[11C]NNC-112	[11C]NNC-112	Phase 2 Clinical	Glaxosmithkline Plc	Diagnostic agents	상세
Lu-AF-28996		Phase 1 Clinical	H. Lundbeck A/S	Parkinson Disease	상세
asenapine schizophrenia (Livzon Pharmaceutical/LTS Lohmann Therapie-Systeme)		Phase 1 Clinical	Lts Lohmann Therapie-Systeme Ag	Schizophrenia	상세
Olanzapine intranasal (Neurelis)	NRL-4; NRL-1004	Phase 1 Clinical	Neurelis Inc	Bipolar Disorder	상세
Oxytocin/Methylergometrine Maleate		Phase 1 Clinical	Nanjing Gritpharma Co Ltd	Hemorrhage; Obstetric Labor Complications	상세
ITI-333	ITI-333	Phase 1 Clinical	Intra-Cellular Therapies Inc	Mood Disorders; Opioid-Related Disorders; Pain	상세
PF-06730110	PF-06730110; [18F]MNI-968	Phase 1 Clinical	Invicro Llc	Nerve Degeneration	상세

시판 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	가장 빠른 브랜드 이름	가장 빠른 승인 국가	가장 빠른 적응증	가장 빠른 승인 회사	가장 빠른 승인 날짜	적응증	임상 시험
Docarpamine	TA-870; TA-8704	Approved		Tanadopa		Heart Failure	null	1994-01-01	Heart Failure	상세
Olanzapine/Fluoxetine hydrochloride	OFC	Approved	Eli Lilly And Company	Symbyax	Mainland China	Bipolar I Disorder	Jiangsu Changtai Pharmaceutical Co Ltd	2003-12-24	Bipolar Disorder; Bipolar I Disorder; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant	상세
Zuclopenthixol Hydrochloride	LU-0108	Approved		Clopixol		Bipolar Disorder; Schizophrenia	null	1962-01-01	Bipolar Disorder; Schizophrenia	상세
Methylergometrine Maleate		Approved		Metenarin, Methergine, Ryegonivin, Basofortina, Methylergobrevin	Japan	Postpartum Hemorrhage	Aska Pharmaceutical Co Ltd	1971-05-01	Postpartum Hemorrhage; Uterine Cervical Incompetence; Uterine Hemorrhage; Uterine Inertia	상세
Samidorphan/Olanzapine	ALKS-3831	Approved	Alkermes Plc	Lybalvi	United States	Bipolar Disorder; Schizophrenia	Alkermes Inc	2021-05-28	Alcoholism; Bipolar and Related Disorders; Bipolar Disorder; Bipolar I Disorder; Psychotic Disorders; Schizophrenia	상세
Olanzapine	ALKS-7921; LY-170052; LY-170053; INP-105; BR-5402; QLG-2072; QLG2072	Approved	Eli Lilly And Company	Zyprexa Zydis, Zyprexa Relprevv, Olansek, Zalasta, Zyprexa, Zyprexa Velotab, Olanzapine ODF, Lanzac, Zypadhera, 再普乐, Midax	EU	Bipolar Disorder; Schizophrenia	null	1996-09-27	Anorexia; Anorexia Nervosa; Autistic Disorder; Biliary Tract Neoplasms; Bipolar Disorder; Bipolar I Disorder; Bipolar II Disorder; Borderline Personality Disorder; Cachexia; Carcinoma, Hepatocellular; Chemotherapy-induced nausea and vomiting; Colorectal Neoplasms; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Emergence Delirium; Esophageal Neoplasms; Fasting; Feeding and Eating Disorders; Gambling; Hematopoietic stem cell transplantation (HSCT); Insulin Resistance; Lung Neoplasms; Malaria, Falciparum; Multiple Myeloma; Nausea; Neoplasms; Opioid-Related Disorders; Postoperative Nausea and Vomiting; Schizophrenia; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Substance-Related Disorders; Tinnitus; Vomiting; Weight Loss	상세
Phenylpropanolamine Hydrochloride		Approved		Nasadec, Nasathera, Pararhinol					Nasal Obstruction	상세
Olanzapine Oral Soluble Film(Jiangsu Hansoh)		Approved	Jiangsu Hansoh Pharmaceutical Group Co Ltd		Mainland China	Schizophrenia; Bipolar Disorder	Jiangsu Hansoh Pharmaceutical Group Co Ltd	2020-11-24	Bipolar Disorder; Schizophrenia	상세
Olanzapine Oral Soluble Film(Qilu Pharma)		Approved	Qilu Pharmaceutical Co Ltd		Mainland China	Bipolar Disorder; Schizophrenia	Qilu Pharmaceutical Co Ltd	2021-01-19	Bipolar Disorder; Schizophrenia	상세
Stepholidine		Approved			Mainland China	Attention Deficit Disorder with Hyperactivity; Tourette Syndrome; Migraine Disorders; Headache	null	1995-01-01	Attention Deficit Disorder with Hyperactivity; Headache; Migraine Disorders; Tourette Syndrome	상세